《高盛認股證牛熊證》保險股強勢中人壽、平保領銜藍籌 留意熱門平安購16597，高槓桿中壽購16603
平保(2318)
正股表現：平保自上週二起錄得四連跌，當中上週五跌約0.7%。今早則低開約0.6%後隨即反彈，現報86.5元，升約2.2%，跑贏大市。有券商指由於國內代理活動率尚未完全復甦，平保上月個人新業務價值按年下跌15%，但券商仍看好其後市表現，維持「跑贏大市」評級，目標價103元。
資金流向：觀察個股認股證資金流向，可見上週五資金轉向部署認購證，錄得約130萬元資金流入。此外，今早亦見認購證獲資金關注。
產品選擇：投資者如看好，可留意價外幅度約9%，年期約3個月，屬資金熱門條款的平安購16597。貼價的選擇則可留意價外幅度約6%，年期約2個月的高槓桿平安購28833。
平安購16597，行使價95.05元，2020年10月27日到期，實際槓桿15.1倍，資金熱門條款
平安購28833，行使價91.93元，2020年09月25日到期，實際槓桿15.1倍，貼價、高槓桿
中人壽(2628)
正股表現：中人壽上週五升約0.7%，今早則高開約1%後升幅擴大。現報19.24元，升約6.8%，屬現時升幅最大的藍籌股。有券商料中人壽今年上半年的新業務價值可增長6.5。該行維持中人壽「跑贏大市」投資評級，目標價30元。
產品選擇：投資者如看好，可考慮以行使價20至24元作為篩選認購證的條件。並可留意當中年期約5個月的低街貨、低面值中壽購17632。並可留意上述行使價區域的產品中，槓桿最突出的中壽購16603。
中壽購17632，行使價23.28元，2020年12月23日到期，實際槓桿6.2倍，低街貨、低面值
中壽購16603，行使價24.29元，2020年11月25日到期，實際槓桿7.5倍，行使價20至24元間產品中，槓桿最高
註: 以上數據資料來自高盛認股證牛熊證網站~
重要聲明:
以上資訊由第三方提供，AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告，不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料，本公司亦不負品質保證之責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
